The anti-cancer effect of epigallocatechin-3-O-gallate against multiple myeloma cells is potentiated by 5,7-dimethoxyflavone

FEBS Open Bio. 2023 Nov;13(11):2147-2156. doi: 10.1002/2211-5463.13708. Epub 2023 Sep 25.

Abstract

(-)-Epigallocatechin-3-O-gallate (EGCG) is one of the major components of green tea polyphenol. Previous studies have shown that EGCG induces cancer-specific cell death in vitro and in vivo without causing severe side effects. However, the anti-cancer effect of EGCG alone is limited. 5,7-dimethoxyflavone (5,7-DMF), one of the principal functional components of black ginger (Kaempferia parviflora), also exerts anti-cancer effects. Here, we show that 5,7-DMF synergistically enhances the anti-cancer effect of EGCG in multiple myeloma cells by potentiating EGCG-induced intracellular cyclic guanosine monophosphate (cGMP) production. Moreover, the combination of EGCG and 5,7-DMF induces apoptotic cell death in multiple myeloma cells, and this is accompanied by activation of the cGMP/acid sphingomyelinase (ASM)/cleaved caspase-3 pathway. In conclusion, we have shown that 5,7-DMF enhances the anti-cancer effect of EGCG by upregulating cGMP in multiple myeloma cells.

Keywords: (−)-epigallocatechin-3-O-gallate; 5,7-dimethoxyflavone; acid sphingomyelinase; cyclic guanosine monophosphate; multiple myeloma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Catechin* / pharmacology
  • Cell Line, Tumor
  • Humans
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / metabolism

Substances

  • epigallocatechin gallate
  • 5,7-dimethoxyflavone
  • Catechin